Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
PRNewswire - November 28, 2008
At its core, PEPFAR has given the promise of life to millions. Now, with the presidential signing of the $48 billion Lantos-Hyde Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act, USAID continues the important and vital work of the Emergency Plan, along with other U.S. Government partners, host countries and dedicated staff in the field.
Specifically within the scope of HIV/AIDS programs, we will continue to focus on strengthening and sustaining health systems, particularly targeting the needs of an overburdened health care workforce.
We will develop additional programs that aim to reduce the spread of HIV/AIDS, such as encouraging delayed sexual debut, being faithful to one partner, and using condoms consistently and correctly. We will also work on programs that reduce women's risk of violence and HIV infection.
We will strengthen our response to the AIDS crisis by further integrating HIV/AIDS into other important development areas. For instance, increasing access to education, helping individuals generate income, and providing nutritional support to those living with and affected by HIV/AIDS are key interventions.
Furthermore, we will continue our work in the areas of policy analysis and legislative strengthening. These strategies foster environments that allow people living and affected by HIV/AIDS to be treated fairly, as full and active members of their communities.
On World AIDS Day, we celebrate life. In countless communities around the world, through partnerships with the American people, courageous individuals in nations devastated by HIV/AIDS are choosing life, saving the lives of their fellow countrymen and women, and creating hope for a future free of HIV/AIDS.
The American people, through the U.S. Agency for International Development, have provided economic and humanitarian assistance worldwide for nearly 50 years.
Public Information: 202-712-4810
Source: USAID
CONTACT: Press Office, +1-202-712-4320, for USAID
Web site: http://www.usaid.gov/
081128
PR081150
Copyright © 2008 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .